Following the surgery, all patients were treated according to current guidelines regarding coronary artery disease, including B-blockers, antiplatelets, statins, and angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers. The gene discussed is ACE; the disease is coronary artery disorder.